Charles River Laboratories International, Inc.
Status: Publicly traded
Direct answer
Charles River Laboratories International, Inc. is publicly traded on NYSE under the ticker CRL.
Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, and the Asia Pacific...
Can you invest in Charles River Laboratories International, Inc.?
Yes. Charles River Laboratories International, Inc. trades publicly on NYSE as CRL.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Charles River Laboratories International, Inc.
Detailed equity research is provided by MarketSnap.